Logo image of ANRG.CA

ANAERGIA INC-SUB VOTING SHR (ANRG.CA) Stock Fundamental Analysis

TSX:ANRG - Toronto Stock Exchange - CA03253E2069 - Common Stock - Currency: CAD

1.31  0 (0%)

Fundamental Rating

2

Taking everything into account, ANRG scores 2 out of 10 in our fundamental rating. ANRG was compared to 24 industry peers in the Commercial Services & Supplies industry. ANRG may be in some trouble as it scores bad on both profitability and health. ANRG is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year ANRG has reported negative net income.
In the past year ANRG has reported a negative cash flow from operations.
In the past 5 years ANRG always reported negative net income.
In the past 5 years ANRG reported 4 times negative operating cash flow.
ANRG.CA Yearly Net Income VS EBIT VS OCF VS FCFANRG.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

Looking at the Return On Assets, with a value of -17.26%, ANRG is doing worse than 75.00% of the companies in the same industry.
Industry RankSector Rank
ROA -17.26%
ROE N/A
ROIC N/A
ROA(3y)-30.26%
ROA(5y)-19.89%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ANRG.CA Yearly ROA, ROE, ROICANRG.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

The Gross Margin of ANRG (22.01%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ANRG has remained more or less at the same level.
ANRG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.61%
GM growth 5Y-1.13%
ANRG.CA Yearly Profit, Operating, Gross MarginsANRG.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

0

2. Health

2.1 Basic Checks

ANRG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ANRG has more shares outstanding
The number of shares outstanding for ANRG has been increased compared to 5 years ago.
The debt/assets ratio for ANRG is higher compared to a year ago.
ANRG.CA Yearly Shares OutstandingANRG.CA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
ANRG.CA Yearly Total Debt VS Total AssetsANRG.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of -2.93, we must say that ANRG is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ANRG (-2.93) is worse than 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.93
ROIC/WACCN/A
WACC7.21%
ANRG.CA Yearly LT Debt VS Equity VS FCFANRG.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

A Current Ratio of 0.81 indicates that ANRG may have some problems paying its short term obligations.
The Current ratio of ANRG (0.81) is worse than 66.67% of its industry peers.
A Quick Ratio of 0.73 indicates that ANRG may have some problems paying its short term obligations.
ANRG has a Quick ratio of 0.73. This is in the lower half of the industry: ANRG underperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.73
ANRG.CA Yearly Current Assets VS Current LiabilitesANRG.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 91.01% over the past year.
Looking at the last year, ANRG shows a very negative growth in Revenue. The Revenue has decreased by -17.72% in the last year.
ANRG shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.47% yearly.
EPS 1Y (TTM)91.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%79.7%
Revenue 1Y (TTM)-17.72%
Revenue growth 3Y-4.2%
Revenue growth 5Y4.47%
Sales Q2Q%-0.37%

3.2 Future

Based on estimates for the next years, ANRG will show a very strong growth in Earnings Per Share. The EPS will grow by 318.72% on average per year.
Based on estimates for the next years, ANRG will show a very strong growth in Revenue. The Revenue will grow by 204.50% on average per year.
EPS Next Y4.76%
EPS Next 2Y318.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year22.06%
Revenue Next 2Y204.5%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ANRG.CA Yearly Revenue VS EstimatesANRG.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
ANRG.CA Yearly EPS VS EstimatesANRG.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 2 -2

4

4. Valuation

4.1 Price/Earnings Ratio

ANRG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
ANRG is valuated cheaply with a Price/Forward Earnings ratio of 0.39.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ANRG indicates a rather cheap valuation: ANRG is cheaper than 100.00% of the companies listed in the same industry.
ANRG is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.15, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 0.39
ANRG.CA Price Earnings VS Forward Price EarningsANRG.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ANRG.CA Per share dataANRG.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ANRG's earnings are expected to grow with 318.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y318.72%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ANRG!.
Industry RankSector Rank
Dividend Yield N/A

ANAERGIA INC-SUB VOTING SHR

TSX:ANRG (5/30/2025, 7:00:00 PM)

1.31

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)05-12 2025-05-12/amc
Earnings (Next)N/A N/A
Inst Owners4.09%
Inst Owner ChangeN/A
Ins Owners17.43%
Ins Owner ChangeN/A
Market Cap222.49M
Analysts42.22
Price Target1.33 (1.53%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)12.47%
Min EPS beat(2)-47.06%
Max EPS beat(2)71.99%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-3.39%
Min Revenue beat(2)-7.97%
Max Revenue beat(2)1.18%
Revenue beat(4)1
Avg Revenue beat(4)-22.3%
Min Revenue beat(4)-44.27%
Max Revenue beat(4)1.18%
Revenue beat(8)2
Avg Revenue beat(8)-20.38%
Revenue beat(12)2
Avg Revenue beat(12)-20.45%
Revenue beat(16)2
Avg Revenue beat(16)-21.55%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)16.67%
EPS NQ rev (3m)16.67%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.39
P/S 1.99
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.25
EYN/A
EPS(NY)3.33
Fwd EY253.98%
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS0.66
BVpS-0.36
TBVpS-0.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.26%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.01%
FCFM N/A
ROA(3y)-30.26%
ROA(5y)-19.89%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.61%
GM growth 5Y-1.13%
F-Score4
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 166.44%
Cap/Sales 8.7%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.81
Quick Ratio 0.73
Altman-Z -2.93
F-Score4
WACC7.21%
ROIC/WACCN/A
Cap/Depr(3y)1470.76%
Cap/Depr(5y)2019.96%
Cap/Sales(3y)40.34%
Cap/Sales(5y)55.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)91.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%79.7%
EPS Next Y4.76%
EPS Next 2Y318.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.72%
Revenue growth 3Y-4.2%
Revenue growth 5Y4.47%
Sales Q2Q%-0.37%
Revenue Next Year22.06%
Revenue Next 2Y204.5%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y36.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year64.29%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y84.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y66.77%
OCF growth 3YN/A
OCF growth 5YN/A